SEC Form 4 · accession 0001596771-15-000068

Diplomat Pharmacy, Inc. · DPLO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer · Director

Period of report

Aug 26, 2015

Accepted (ET)

Aug 27, 2015 · 5:04 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001610092

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Aug 26, 2015	M	290,064	$4.29	A	292,064	D
Common Stock^F1	Aug 26, 2015	S	119,852	$37.8963	D	172,212	D
Common Stock^F2	Aug 26, 2015	S	29,682	$38.6003	D	142,530	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Option to Acquire Common Stock^F3	$4.29	Aug 26, 2015	M	290,064	D	—	Mar 1, 2022	Common Stock	290,064	96,686	D

F1The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $37.48 to $38.33 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
F2The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $38.40 to $38.98 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
F3The options were granted on 03/01/2012 and began to vest in annual increments of 25% of the option grant on the one-year anniversary of the date of grant, to be fully vested after four years. The remaining 96,686 options vest on 03/01/2016.